NeuBase Therapeutics, Inc. Income (Loss) from Continuing Operations, Per Basic Share
NeuBase Therapeutics, Inc. reported Income (Loss) from Continuing Operations, Per Basic Share of $0.01 per share for the 3-month period ending 2011-12-31, per its 10-Q/A filed 2012-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare · last filed 2012-02-14
- NeuBase Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2011-12-31 was $0.01.
- NeuBase Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2011-06-30 was -$0.08.
- NeuBase Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2010-12-31 was -$0.01.
- NeuBase Therapeutics, Inc. income (loss) from continuing operations, per basic share for the quarter ending 2010-06-30 was $0.00.
| Period end | Income (Loss) from Continuing Operations, Per Basic Share 3 month | Income (Loss) from Continuing Operations, Per Basic Share 9 month |
|---|---|---|
| 2011-12-31 | $0.01 10-Q/A · filed 2012-02-14 | |
| 2011-06-30 | -$0.08 10-Q · filed 2011-08-15 | -$0.10 10-Q · filed 2011-08-15 |
| 2010-12-31 | -$0.01 10-Q/A · filed 2012-02-14 | |
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | -$0.02 10-Q · filed 2011-08-15 |